Status: Recruiting
Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
The goal of this clinical trial is to learn about the induction chemotherapy efficacy in olfactory neuroblastoma. The main question it aims to answer is: wether olfactory neuroblastoma patients with different pathology subtypes apply to different induction chemotherapy schemes. Participants will be treated with different chemotherapy schemes, to evaluate the tumor remission rate and long term survival.
Participants needed: 25
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Hongmeng YuUpdated: Feb 13, 2024Locations: 1
Eligibility criteria
Patients with pathologically confirmed olfactory neuroblastoma; [+4]
Patients with uncontrolled concurrent diseases that the researchers believe will... [+6]